Torrent Pharmaceuticals (NSE:TORNTPHARM) Institutional Ownership: 19.62% (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
88 GF Score
Price ₹4,833.00
GF Value ₹4,559.73
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Institutional Ownership?

Torrent Pharmaceuticals NSE:TORNTPHARM -1.66% 88 Institutional Ownership is 19.62% as of Aug. 17, 2026. GuruFocus rates NSE:TORNTPHARM with a GF Score™ of 88/100 and a GF Value™ of ₹4,559.73 (Fairly Valued). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Torrent Pharmaceuticals's institutional ownership is 19.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Torrent Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Torrent Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Torrent Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Institutional Ownership Chart

Torrent Pharmaceuticals Historical Data

The historical data trend for Torrent Pharmaceuticals can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 19.71 19.76 19.93 19.40 18.44 18.62 18.25 18.10 18.16 19.62
NSE:TORNTPHARM
88GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 19.62% mean?
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Institutional Ownership of 19.62% as of Aug. 17, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' Institutional Ownership too high?
Torrent Pharmaceuticals' current Institutional Ownership is 19.62%. Overall, Torrent Pharmaceuticals has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Institutional Ownership compare to ZTS?
Torrent Pharmaceuticals' Institutional Ownership of 19.62% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current Institutional Ownership is 19.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,559.73, compared to a current price of ₹4,833.00 — trading 6% above its estimated fair value. The current Institutional Ownership is 19.62%. Torrent Pharmaceuticals' overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Institutional Ownership is 19.62% as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,833.00 is trading 6% above its estimated GF Value™ of ₹4,559.73. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:TORNTPHARM:

  • Institutional Ownership: 19.62%
  • GF Value™: ₹4,559.73 vs. price of ₹4,833.00 (6% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
88GF Score

Get the complete analysis for NSE:TORNTPHARM

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,833.00
Price
₹4,559.73
GF Value